Celularity Statistics
Share Statistics
Celularity has 23.95M
shares outstanding. The number of shares has increased by 9.3%
in one year.
| Shares Outstanding | 23.95M |
| Shares Change (YoY) | 9.3% |
| Shares Change (QoQ) | 5.89% |
| Owned by Institutions (%) | 0.05% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 13,148 |
| FTD / Avg. Volume | 12.41% |
Short Selling Information
The latest short interest is 1.61M, so 6.7% of the outstanding
shares have been sold short.
| Short Interest | 1.61M |
| Short % of Shares Out | 6.7% |
| Short % of Float | 35.41% |
| Short Ratio (days to cover) | 15.68 |
Valuation Ratios
The PE ratio is -0.79 and the forward
PE ratio is -0.52.
Celularity's PEG ratio is
0.01.
| PE Ratio | -0.79 |
| Forward PE | -0.52 |
| PS Ratio | 0.84 |
| Forward PS | 0.2 |
| PB Ratio | 5.15 |
| P/FCF Ratio | -6.94 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Celularity.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38,
with a Debt / Equity ratio of 3.29.
| Current Ratio | 0.38 |
| Quick Ratio | 0.28 |
| Debt / Equity | 3.29 |
| Debt / EBITDA | -0.76 |
| Debt / FCF | -4.42 |
| Interest Coverage | 6.12 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $451,833.33 |
| Profits Per Employee | $-482,433.33 |
| Employee Count | 120 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -21.81% in the
last 52 weeks. The beta is 0.61, so Celularity's
price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | -21.81% |
| 50-Day Moving Average | 1.78 |
| 200-Day Moving Average | 2.2 |
| Relative Strength Index (RSI) | 60.23 |
| Average Volume (20 Days) | 105,954 |
Income Statement
In the last 12 months, Celularity had revenue of 54.22M
and earned -57.89M
in profits. Earnings per share was -2.64.
| Revenue | 54.22M |
| Gross Profit | 45.33M |
| Operating Income | -38.36M |
| Net Income | -57.89M |
| EBITDA | -38.36M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.64 |
Full Income StatementBalance Sheet
The company has 738K in cash and 29.03M in
debt, giving a net cash position of -28.3M.
| Cash & Cash Equivalents | 738K |
| Total Debt | 29.03M |
| Net Cash | -28.3M |
| Retained Earnings | -899.68M |
| Total Assets | 132.68M |
| Working Capital | -33.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -6.4M
and capital expenditures -161K, giving a free cash flow of -6.56M.
| Operating Cash Flow | -6.4M |
| Capital Expenditures | -161K |
| Free Cash Flow | -6.56M |
| FCF Per Share | -0.3 |
Full Cash Flow StatementMargins
Gross margin is 83.6%, with operating and profit margins of -70.75% and -106.77%.
| Gross Margin | 83.6% |
| Operating Margin | -70.75% |
| Pretax Margin | -106.77% |
| Profit Margin | -106.77% |
| EBITDA Margin | -70.75% |
| EBIT Margin | -70.75% |
| FCF Margin | -12.1% |
